Treatment outcomes and patient-reported quality of life after orthognathic surgery with computer-assisted 2-or 3-dimensional planning: A randomized double-blind active-controlled clinical trial

被引:21
|
作者
Bengtsson, Martin [1 ]
Wall, Gert [1 ]
Larsson, Pernilla [2 ,3 ]
Becktor, Jonas P. [4 ]
Rasmusson, Lars [5 ]
机构
[1] Univ Hosp Skane, Dept Oral & Maxillofacial Surg, S-22185 Lund, Sweden
[2] Ostergotland Cty Council, Ctr Oral Rehabil, Linkoping, Sweden
[3] Malmo Univ, Fac Odontol, Dept Orofacial Pain & Jaw Funct, Malmo, Sweden
[4] Malmo Univ, Fac Odontol, Dept Oral & Maxillofacial Surg & Oral Med, Malmo, Sweden
[5] Gothenburg Univ, Sahlgrenska Acad, Dept Oral & Maxillofacial Surg, Gothenburg, Sweden
关键词
OROFACIAL AESTHETIC SCALE; CAD/CAM SURGICAL SPLINTS; DISTRACTION OSTEOGENESIS; PROSTHODONTIC PATIENTS; SWEDISH VERSION; ACCURACY; SIMULATION; IMPACT; RELIABILITY; VALIDITY;
D O I
10.1016/j.ajodo.2017.12.008
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Introduction: Thorough treatment planning is essential for a good clinical outcome in orthognathic treatment. The planning is often digital. Both 2-dimensional (2D) and 3-dimensional (3D) software options are available. The aim of this randomized 2-arm parallel double-blinded active-controlled clinical trial was to comprae the outcomes of computer-based 2D and 3D planning techniques according to patient-reported health related quality of life. The hypothesis was that a 3D technique would give a better treatment outcome compared with a 2D technique. Methods: Orthognathic treatment for 62 subjects, aged 18 to 28 years, with severe Class III malocclusion was planned with both 2D and 3D techniques. After treatment planning but before surgery, the patients were randomly allocated via blind collection of 1 enveloped card for each subject in a 1:1 ratio to the test (3D) or the control (2D) group. Thus, the intervention was according to which planning technique was used. The primary outcome was patient-reported outcome measures. The secondary outcome was relationship between patient-reported outcome measures and cephalometric accuracy. Questionnaires on the patient's health-related quality of life (HRQoL) were distributed preoperatively and 12 months after surgical treatment. The questionnaires were coded, meaning blinding throughout the analysis. Differences between groups were tested with the Fisher permutation test. The HRQoL was also compared with measurements of cephalometric accuracy for the 2 groups. Reslts: Three subjects were lost to clinical follow-up leaving 57 included. Of these, 55 subjects completed the questionnaires, 28 in the 2D and 27 in the 3D groups. No statistically significant difference regarding HRQoL was found between the studied planning techniques: the Oral Health Impact Profile total showed -3.69 (95% confidence interval, -19.68 to 12.30). Consistent results on HRQoL and cephalometric accuracy showed a difference between pretreatment and postreatment that increased in both groups but to a higher level in the 3D group. A difference between pretreatment and posttreatment HRQoL was shown for both groups, indicating increased quality of life after treatment. This supports recent findings comparing 3D and 2D planning techniques. No serious harm was observed during the study. Conclusions: Improvemens of HRQoL were shown after treatment independent of which planning technique, 2D or 3D, was used. No statisticaly significant difference was found between the planning techniqes. Registration: This trial was not registered. Protocol: The protocol was not published before trial commencement.
引用
收藏
页码:786 / 796
页数:11
相关论文
共 47 条
  • [21] Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus: Post Hoc Analyses of Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-blind, Placebo-Controlled Trial
    Askanase, Anca
    Wan, George
    Panaccio, Mary
    Zhao, Enxu
    Zhu, Julie
    Bilyk, Roman
    Furie, Richard
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [22] Vitamin D3 repletion versus placebo as adjunctive treatment of heart failure patient quality of life and hormonal indices: a randomized, double-blind, placebo-controlled trial
    Heidi D. Moretti
    Vincent J. Colucci
    Bradley D. Berry
    BMC Cardiovascular Disorders, 17
  • [23] Vitamin D3 repletion versus placebo as adjunctive treatment of heart failure patient quality of life and hormonal indices: a randomized, double-blind, placebo-controlled trial
    Moretti, Heidi D.
    Colucci, Vincent J.
    Berry, Bradley D.
    BMC CARDIOVASCULAR DISORDERS, 2017, 17
  • [24] Twice-daily balsalazide tablets improve patient quality of life after 2 and 8 weeks of treatment: Results of a phase 3, randomized, double-blind, placebo-controlled, multicenter study
    Rubin, David T.
    Rosen, Alan A.
    Sedghi, Shahriar
    Shepard, Roland D.
    Mareya, Shadreck M.
    Huang, Shirley
    Shaw, Audrey L.
    Forbes, William P.
    GASTROENTEROLOGY, 2008, 134 (04) : A494 - A494
  • [25] Photobiomodulation self-treatment at home after rotator cuff arthroscopic repair accelerates improvement in pain, functionality, and quality of life: A double-blind, sham-controlled, randomized clinical trial
    Abufoul, Rabie
    Gavish, Lilach
    Haddad, Marwan
    LASERS IN SURGERY AND MEDICINE, 2023, 55 (07) : 662 - 673
  • [26] Ongoing clinical trial: PESTO, a prospective multicenter, phase 2b randomized controlled double-blind trial, to determine the safety and efficacy of perispinal etanercept on quality of life at 28 days post treatment
    Thijs, V
    Bernhardt, J.
    Churilov, L.
    Sprigg, N.
    Cloud, G.
    Parsons, B.
    Jafari, S.
    Walker, M.
    Gilchrist, N.
    Bath, P.
    INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (1_SUPPL) : 30 - 30
  • [27] Secukinumab improves physical function, quality of life, fatigue and work productivity in patients with active psoriatic arthritis: Results of a randomized, double-blind, placebo-controlled phase 3 trial (FUTURE 2)
    Gottlieb, A. B.
    Strand, V.
    McInnes, I. B.
    Marzo-Ortega, H.
    Kavanaugh, A.
    Kandala, S.
    Pricop, L.
    Mpofu, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S30 - S30
  • [28] Comparisons and correlations of 1-month recall vs 24-hour recall in patient-reported outcomes of an exploratory, phase 2b, randomized, double-blind, placebo-controlled clinical trial of sildenafil cream, 3.6% for the treatment of female sexual arousal disorder
    Johnson, Isabella
    Thurman, Andrea Ries
    Cornell, Katherine A.
    Symonds, Tara
    Hatheway, Jessica
    Friend, David R.
    Goldstein, Andrew
    JOURNAL OF SEXUAL MEDICINE, 2024, 21 (09): : 787 - 792
  • [29] Association Between Achievement of Clinical Disease Control and Improvement in Patient-Reported Outcomes and Quality of Life in Patients With Psoriatic Arthritis in the Phase 3 SELECT-PsA 1 and 2 Randomized Controlled Trials
    Kavanaugh, Arthur
    Mease, Philip
    Gossec, Laure
    Ranza, Roberto
    Tsuji, Shigeyoshi
    Douglas, Kevin
    Lane, Michael
    Lippe, Ralph
    Mittal, Manish
    Gao, Tianming
    Setty, Arathi
    Ciecinski, Sandra
    Aletaha, Daniel
    Nash, Peter
    ACR OPEN RHEUMATOLOGY, 2024, 6 (11) : 736 - 745
  • [30] Patient reported outcomes (PROs) of multiple myeloma (MM) patients treated with panobinostat (PAN) after?2 lines of therapy based on the international phase 3, randomized, double-blind, placebo-controlled, PANORAMA-1 trial.
    Richardson, Paul G.
    Lonial, Sagar
    Schlossman, Robert L.
    Roy, Anuja Nidumolu
    Majer, Istvan
    Panneerselvam, Ashok
    Sopala, Monika
    Miguel, Jesus San
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)